Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 381

1.
2.
3.

Prothrombin A19911G polymorphism and the risk of venous thromboembolism.

Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, Mannucci PM.

J Thromb Haemost. 2006 Dec;4(12):2582-6. Epub 2006 Sep 15.

4.

Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.

Ehrenforth S, von Depka Prondsinski M, Aygören-Pürsün E, Nowak-Göttl U, Scharrer I, Ganser A.

Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):276-80.

5.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

6.

Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.

Sartori MT, Simioni P, Patrassi GM, Theodoridis P, Tormene D, Girolami A.

Clin Appl Thromb Hemost. 2000 Jan;6(1):36-40.

PMID:
10726047
7.

Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias.

Villani M, Tiscia GL, Margaglione M, Colaizzo D, Fischetti L, Vergura P, Grandone E.

J Thromb Haemost. 2012 Feb;10(2):223-8. doi: 10.1111/j.1538-7836.2011.04583.x.

8.

Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.

Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.

Thromb Haemost. 2001 Sep;86(3):809-16. Erratum in: Thromb Haemost 2001 Dec;86(6):1598.

PMID:
11583312
10.

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

11.

The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.

Martinelli I, Battaglioli T, De Stefano V, Tormene D, Valdrè L, Grandone E, Tosetto A, Mannucci PM; GIT (Gruppo Italiano Trombofilia).

J Thromb Haemost. 2008 Mar;6(3):494-8. doi: 10.1111/j.1538-7836.2007.02880.x. Epub 2007 Dec 19.

12.

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

Simioni P, Tormene D, Prandoni P, Zerbinati P, Gavasso S, Cefalo P, Girolami A.

Blood. 2002 Mar 15;99(6):1938-42.

13.

Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.

14.

Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.

Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.

Thromb Haemost. 2001 Sep;86(3):800-3.

PMID:
11583310
15.

Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.

Simioni P, Scarano L, Gavasso S, Sardella C, Girolami B, Scudeller A, Girolami A.

Br J Haematol. 1996 Feb;92(2):435-41.

PMID:
8603014
16.

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA.

Arch Intern Med. 2002 Nov 11;162(20):2357-60.

PMID:
12418950
17.

Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Blood Coagul Fibrinolysis. 2001 Dec;12(8):713-20.

PMID:
11734673
18.
19.

Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation.

Rintelen C, Pabinger I, Bettelheim P, Lechner K, Kyrle PA, Knöbl P, Schneider B, Mannhalter C.

Eur J Haematol. 2001 Sep;67(3):165-9.

PMID:
11737249
20.

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.

Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallvé C, Souto JC, Martínez-Sánchez E, Fontcuberta J.

Haematologica. 2001 Nov;86(11):1200-8.

Supplemental Content

Support Center